Keywords
Affiliated Institutions
Related Publications
Inhibition of Metastatic Spread by I.C.R.F. 159: Selective Deletion of a Malignant Characteristic
Treatment with I.C.R.F. 159 completely inhibited metastasis formation in mice implanted with Lewis lung carcinoma at doses having little influence on the rate of growth of the p...
Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma
In patients with unresectable hepatocellular carcinoma, atezolizumab combined with bevacizumab resulted in better overall and progression-free survival outcomes than sorafenib. ...
2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference
This document reflects a process whereby a group of experts and opinion leaders revisited the 1992 sepsis guidelines and found that apart from expanding the list of signs and sy...
Double-blind controlled trial of oral clodronate in patients with bone metastases from breast cancer.
PURPOSE Osteolytic metastases often give rise to hypercalcemia, fracture, and bone pain, and occur commonly in patients with recurrent breast cancer. We assessed the bisphosphon...
Publication Info
- Year
- 1948
- Type
- article
- Volume
- 1
- Issue
- 4
- Pages
- 634-656
- Citations
- 2215
- Access
- Closed
External Links
Social Impact
Social media, news, blog, policy document mentions
Citation Metrics
Cite This
Identifiers
- DOI
- 10.1002/1097-0142(194811)1:4<634::aid-cncr2820010410>3.0.co;2-l